prikaz prve stranice dokumenta Is there any association between plasma lipid profile and severity of COVID-19?
  Preuzmi
PDF 357.94 KB
Znanstveni rad - Izvorni znanstveni rad
Is there any association between plasma lipid profile and severity of COVID-19?
Clinical Nutrition ESPEN, 49 (2022); 191-196. https://doi.org/10.1016/j.clnesp.2022.04.026
Rahimibashar, Farshid; Sedighi, Ladan; Shahriary, Alireza; Reiner, Željko; Pourhoseingholi, Mohamad Amin; Mirmomeni, Golshan; Jouzdani, Ali Fathi; Vahedian-Azimi, Amir; Jamialahmadi, Tannaz; Sahebkar, Amirhossein

Citirajte ovaj rad

Rahimibashar, F., Sedighi, L., Shahriary, A., Reiner, Ž., Pourhoseingholi, M. A., Mirmomeni, G. ... Sahebkar, A. (2022). Is there any association between plasma lipid profile and severity of COVID-19?. Clinical Nutrition ESPEN, 49., 191-196. doi: 10.1016/j.clnesp.2022.04.026

Rahimibashar, Farshid, et al. "Is there any association between plasma lipid profile and severity of COVID-19?." Clinical Nutrition ESPEN, vol. 49, 2022, str. 191-196. https://doi.org/10.1016/j.clnesp.2022.04.026

Rahimibashar, Farshid, Ladan Sedighi, Alireza Shahriary, Željko Reiner, Mohamad Amin Pourhoseingholi, Golshan Mirmomeni, Ali Fathi Jouzdani, Amir Vahedian Azimi, Tannaz Jamialahmadi i Amirhossein Sahebkar. "Is there any association between plasma lipid profile and severity of COVID-19?." Clinical Nutrition ESPEN 49 (2022): 191-196. https://doi.org/10.1016/j.clnesp.2022.04.026

Rahimibashar, F., et al. (2022) 'Is there any association between plasma lipid profile and severity of COVID-19?', Clinical Nutrition ESPEN, 49, str. 191-196. doi: 10.1016/j.clnesp.2022.04.026

Rahimibashar F, Sedighi L, Shahriary A, Reiner Ž, Pourhoseingholi MA, Mirmomeni G, i sur.. Is there any association between plasma lipid profile and severity of COVID-19?. Clinical Nutrition ESPEN [Internet]. 06.2022. [pristupljeno 08.05.2024.];49:191-196. doi: 10.1016/j.clnesp.2022.04.026

F. Rahimibashar, et al., "Is there any association between plasma lipid profile and severity of COVID-19?", Clinical Nutrition ESPEN, vol. 49, str. 191-196, Lipanj 2022. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:105:761856. [Citirano: 08.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:105:761856
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Is there any association between plasma lipid profile and severity of COVID-19?
AutorFarshid Rahimibashar
AutorLadan Sedighi
AutorAlireza Shahriary
AutorŽeljko Reiner
AutorMohamad Amin Pourhoseingholi
AutorGolshan Mirmomeni
AutorAli Fathi Jouzdani
AutorAmir Vahedian-Azimi
AutorTannaz Jamialahmadi
AutorAmirhossein Sahebkar
Autorova ustanovaSveučilište u Zagrebu
Medicinski fakultet
(KATEDRA ZA INTERNU MEDICINU)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Kliničke medicinske znanosti
Interna medicina
Sažetak (engleski)
Background: COVID-19 is an infectious disease which caused a pandemic with many diseases and fatalities. This new variant of coronavirus called SARS-CoV-2 and is primarily characterized by respiratory symptoms. There are some data indicating that LDL-cholesterol (LDL-C) as well as HDL-cholesterol (HDL-C) levels are inversely correlated to disease severity and could act as a predictor for disease progression and unfavorable prognosis. However, the results of some other studies do not confirm this. This current study aimed to provide an answer to this question. ----- Methods: This prospective, single-center study analyzed 367 confirmed COVID-19 patients to find whether there are any differences in plasma lipoproteins between survivors and non-survivors patients or between the patients with a "duration of ≤10 days intensive unit care (ICU) stay" and patients with a "duration of >10 days ICU stay". ----- Results: No association between any lipid/lipoprotein parameter and the severity of COVID-19 could be found but survivors and non-survivors did differ concerning total cholesterol and LDL-C levels. ----- Conclusion: Multivariate cox regression analysis could not prove any association between lipids/lipoproteins and severe events in COVID-19 patients. Significantly less non-survivors with COVID-19 were taking atorvastatin than survivors which is consistent with the majority of previous findings.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran
Verzija publikacijeObjavljena verzija rada (izdavačev PDF)
Naslov časopisaClinical Nutrition ESPEN
Brojčani podacivol. 49, str. 191-196
p-ISSN2405-4577
DOIhttps://doi.org/10.1016/j.clnesp.2022.04.026
URN:NBNurn:nbn:hr:105:761856
Datum objave publikacije2022-06
URL dokumentahttps://linkinghub.elsevier.com/retrieve/pii/S2405457722002522
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Zaštićeno autorskim pravom.
Datum i vrijeme pohrane2022-12-15 08:08:32